For more than two decades, the dominant paradigm for explaining pharmaceutical pricing has been value. That value was defined by clinical benefit, improved patient outcomes or experience, and

November 2025 may ultimately be remembered as a pivotal moment in how the United States understands and treats obesity. Last month, federal regulators announced an

A new election cycle is upon us, which means America is once again scrolling its way through headlines, policy debates, and an endless stream of

Access to quality health care is something we all want. We all benefit from medical progress, innovative care and new technologies that help people live healthier lives. When people are healthy, families, communities and societies

America’s medicine cabinet hasn’t kept pace with its health care needs. While digital tools and consumer empowerment have transformed nearly every facet of modern health

Policy has always influenced how the biopharmaceutical industry communicates the value of its medicines. However, today’s value communicators must be more agile than ever. In